Macquarie Group LTD Alkermes Plc. Transaction History

Macquarie Group LTD

$90.3 Billion
Q3 2024

A detailed history of Macquarie Group LTD transactions in Alkermes Plc. stock. As of the latest transaction made, Macquarie Group LTD holds 300,000 shares of ALKS stock, worth $8.63 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

300,000

Previous 300,000 -0.0%

Holding current value

$8.63 Million

Previous $7.23 Million 16.14%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$28.34 - $33.63 $3.49 Million - $4.14 Million	-123,142 Reduced 29.1%	300,000 $9.39 Million
Q4 2022 Feb 21, 2023	SELL	$21.94 - $26.24 $43,485 - $52,007	-1,982 Reduced 0.47%	423,142 $11.1 Million
Q3 2022 Nov 14, 2022	SELL	$22.0 - $31.87 $37,466 - $54,274	-1,703 Reduced 0.4%	425,124 $9.53 Million
Q1 2022 May 16, 2022	SELL	$23.07 - $27.99 $13,842 - $16,794	-600 Reduced 0.14%	426,827 $11.2 Million
Q2 2021 Aug 13, 2021	SELL	$18.78 - $25.15 $25,183 - $33,726	-1,341 Reduced 0.31%	427,427 $10.5 Million
Q1 2021 May 14, 2021	SELL	$18.21 - $23.2 $26,277 - $33,477	-1,443 Reduced 0.34%	428,768 $8.01 Million
Q4 2020 Feb 16, 2021	SELL	$15.39 - $22.1 $15,390 - $22,100	-1,000 Reduced 0.23%	430,211 $8.58 Million
Q3 2020 Nov 13, 2020	BUY	$16.16 - $20.66 $858,774 - $1.1 Million	53,142 Added 14.06%	431,211 $7.15 Million
Q2 2020 Aug 11, 2020	BUY	$13.31 - $19.41 $7,573 - $11,044	569 Added 0.15%	378,069 $7.34 Million
Q1 2020 May 15, 2020	SELL	$13.06 - $21.24 $1.48 Million - $2.41 Million	-113,489 Reduced 23.11%	377,500 $5.44 Million
Q4 2019 Feb 14, 2020	BUY	$17.29 - $21.74 $344,071 - $432,625	19,900 Added 4.22%	490,989 $10 Million
Q3 2019 Nov 14, 2019	BUY	$19.51 - $24.28 $1,307 - $1,626	67 Added 0.01%	471,089 $9.19 Million
Q2 2019 Aug 14, 2019	BUY	$21.47 - $37.33 $2.05 Million - $3.57 Million	95,575 Added 25.46%	471,022 $10.6 Million
Q1 2019 May 15, 2019	BUY	$28.4 - $36.49 $7.61 Million - $9.77 Million	267,838 Added 248.9%	375,447 $13.7 Million
Q4 2018 Feb 15, 2019	BUY	$27.94 - $44.61 $132,715 - $211,897	4,750 Added 4.62%	107,609 $3.18 Million
Q3 2018 Nov 15, 2018	BUY	$38.6 - $46.12 $564,216 - $674,136	14,617 Added 16.56%	102,859 $4.37 Million
Q2 2018 Aug 14, 2018	BUY	$40.56 - $51.36 $45,913 - $58,139	1,132 Added 1.3%	88,242 $3.63 Million
Q1 2018 May 11, 2018	BUY	$53.61 - $67.26 $6,165 - $7,734	115 Added 0.13%	87,110 $5.05 Million
Q4 2017 Feb 15, 2018	SELL	$47.69 - $55.39 $3.95 Million - $4.59 Million	-82,862 Reduced 48.78%	86,995 $4.77 Million
Q3 2017 Nov 08, 2017	BUY	$49.16 - $54.45 $8.35 Million - $9.25 Million	169,857	169,857 $8.64 Million

Others Institutions Holding ALKS

# of Institutions

361

Shares Held

181M

Call Options Held

175K

Put Options Held

96.6K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.73B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Alkermes Plc. Transaction History